维普中文期刊产品整合服务
19篇 您的检索式:作者名="Krasnodebski"
    题名 作者 年代 出处 被引量
1Synchronous occurrence of gastrointestinal stromal tumors and other primary gastrointestinal neoplasms显示文摘AIM: To review clinical and pathologic features of Gas-trointestinal stromal tumors (GISTs) occurring synchro-nously with other primary gastrointestinal neoplasms.METHODS: Twenty-eight patients with primary GIST were treated at our institution between 1989 and 2005. Clinical and pathologic records were reviewed. RESULTS: The gastrointestinal stromal tumor occurred simultaneously with other primary GI malignancies in 14% of all patients with GIST. The synchronous stromal tumors were located in the stomach and were incidentally found during the operation. The coexistent neoplasms were colon adenocarcinoma, gastric cancer (2 cases) and gastric lymphoma.CONCLUSION: The synchronous occurrence of GISTs and other gastrointestinal malignancies is more common than it has been considered. The development of gastrointestinal stromal tumors and other neoplasms may involve the same carcinogenic agents.Marek Wronski Bogna Ziarkiewicz-Wroblewska Barbara Gornicka Wlodzimierz Cebulski Maciej Slodkowski Aleksander Wasiutynski Ireneusz W Krasnodebski 2006World Journal of Gastroenterology2006,12,33:14
2Optimizing management of pancreaticopleural fistulas显示文摘AIM:To evaluate the management of pancreaticopleural fistulas involving early endoscopic instrumentation of the pancreatic duct.METHODS:Eight patients with a spontaneous pancre-aticopleural fistula underwent endoscopic retrograde cholang iopancreatography(ERCP) with an intentionto stent the site of a ductal disruption as the primarytreatment. Imaging features and management were evaluated retrospectively and compared with outcome.RESULTS:In one case,the stent bridged the site of aductal disruption. The fistula in this patient closed with in3 wk. The main pancreatic duct in this case appearednormal,except for a leak located in the body of the pancreas. In another patient,the papilla of Vater couldnot be found and cannulation of the pancreatic ductfailed. This patient underwent surgical treatment. In the remaining 6 cases,it was impossible to insert a stentinto the main pancreatic duct properly so as to coverthe site of leakage or traverse a stenosis situated down-stream to the fistula. The placement of the stent failed because intraductal stones(n = 2) and ductal strictures(n = 2) precluded its passage or the stent was too short to reach the fistula located in the distal part of the pancreas(n = 2) . In 3 out of these 6 patients,the pancre-aticopleural fistula closed on further medical treatment.In these cases,the main pancreatic duct was normalor only mildly dilated,and there was a leakage at the body/tail of the pancreas. In one of these 3 patients,additional percutaneous drainage of the peripancre atic fluid collections allowed better control of the leakageand facilitated resolution of the fistula. The remaining3 patients had a tight stenosis of the main pancreatic duct resistible to dilatation and the stent could not beinserted across the stenosis. Subsequent conservative treatment proved unsuccessful in these patients. Aftera failed the rapeutic ERCP,3 patients in our series developed superinfection of the pleural or peripancreatic fluid collections. Four out of 8 patients in our series required subsequent surgery due to a failed non-operative treat-ment. Distal pancreatectomy with splenectomy was performed in 3 cases. In one case,only external drainage of the pancreatic pseudocyst was done because of diffuse peripancreatic inflammatory infiltration precluding safe dissection. There were no perioperative mortalities.There was no recurrence of a pancreati copleural fistulain any of the patients.CONCLUSION:Optimal management of pancreaticopleural fistulas requires appropriate patient selection that should be based on the underlying pancreatic ductab normalities.Marek Wronski Maciej Slodkowski Wlodzimierz Cebulski Daniel Moronczyk Ireneusz W Krasnodebski 2011World Journal of Gastroenterology2011,17,42:6
3Fulminant liver failure following a marathon: Five case reports and review of literature显示文摘BACKGROUND The growing popularity of marathon and half-marathon runs has led to an increased number of patients presenting with exertion-induced heat stroke. Mild hepatic involvement is often observed in these patients;however, fulminant liver failure may occur in approximately 5% of all cases. Liver transplantation is a potentially curative approach for exertion-induced liver failure, although there is a lack of consensus regarding the criteria and optimal timing of this intervention. CASE SUMMARY This paper describes 5 patients (4 men and 1 woman) who were referred to the department where this study was performed with the diagnosis of exertioninduced acute liver failure. Three patients underwent liver transplantation, 1 recovered spontaneously, and 1 patient died on day 11 following the exertion. CONCLUSION Exertion-induced heat stroke may present as fulminant liver failure. These patients may recover with conservative treatment, may require liver transplantation, or may die. No definitive criteria are available to determine patient suitability for a conservative vs surgical approach.Wojciech Figiel Marcin Morawski Michal Grat Oskar Kornasiewicz Grzegorz Niewiński Joanna Raszeja-Wyszomirska Maciej Krasnodebski Arkadiusz Kowalczyk Waclaw Holówko Waldemar Patkowski Krzysztof Zieniewicz 2019World Journal of Clinical Cases2019,7,12:2
4Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetes mellitus 显示文摘Krasnodebski P Opolski G Karnafel W 2011Kardiol Pol2011,69,9:1
5Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetes mellitus 显示文摘Krasnodebski P Opolski G Kamafd W 2011Kardiol Pol2011,69,9:1
6The role of tumour markers and biomarkers in eolorectal cancer 显示文摘Lech G Slotwinski R Krasnodebski IW 2014Neoplasma2014,61,1:1
7Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetes mellitus显示文摘Krasnodebski P Opolski G Karnafel W 2011Kardiol Pol2011,69,9:1
8Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recov- ery period in patients with type 2 diabetes mellitus 显示文摘Krasnodebski P Opolski G Karnafel W 2011Kardiol Pol2011,69,9:1
9The Soluble Tumor Necrosis Factor Receptor I Is an Early Predictor of Local Infective Complications After Colorectal Surgery显示文摘Robert Slotwiński Waldemar L. Olszewski Andrzej Chaber Maciej Slodkowski Marzanna Zaleska Ireneusz W. Krasnodebski 2002Journal of Clinical Immunology2002,,5:1
10Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetes mellitus显示文摘Krasnodebski P Opolski G Karnafel W 0,,09:1
11Leptin in acute myocar- dial infarction and period of convalescence in patients with type 2 diabetes mellitus 显示文摘Krasnodebski P Bak M I Opolski G 2010Kardiol Po12010,68,6:1
12Fournier's gangrene显示文摘Pawlowski W Wronski M Krasnodebski I W 2004Pol Merkur Lekarski2004,17,97:1
13Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetes mellitus 显示文摘Krasnodebski P Opolski G Kamafel W 2011Kardiol Pol2011,69,9:1
14Effect of narrowing oxirane adduct distribution on some properties of ethoxylated alcohol-based sulfosuccinic acid halfesters显示文摘W HRECZUCH Z KRASNODEBSKI J SZYMANOWSKI 1993Journal of the American Oil Chemists'' Society1993,70,7:1
15Implementation ofthe fast track surgery in patients undergoing the colonicresection: own experience 显示文摘Moronczyk DA Krasnodebski IW 2011Pol Przegl Chir2011,83,9:1
16Plasma adiponectin levels in acute myocardial infarction and during the postinfarction recovery period in patients with type 2 diabetesmellitus显示文摘Krasnodebski P Opolski 6 Karnafel W 0,,:1
17Fournier’s gangrene 显示文摘Paw?owski W Wroński M Krasnodebski IW 2004Pol Merkur Lekarski2004,17,97:1
18The Soluble Tumor Necrosis Factor Receptor I Is an Early Predictor of Local Infective Complications After Colorectal Surgery显示文摘Robert Slotwiński Waldemar L. Olszewski Andrzej Chaber Maciej Slodkowski Marzanna Zaleska Ireneusz W. Krasnodebski 2002Journal of Clinical Immunology2002,,5:1
19Giant gastrointestinal stromal tumour of rare sarcomatoid epithelioid subtype:Case study and literature review显示文摘Gastrointestinal stromal tumours(GISTs) are the most common mesenchymal tumours of the gastrointestinal tract,but they represent less than 3% of all gastrointestinal tract malignancies.This is a detailed case study of a 52-yearold male patient treated for very uncommon histological subtype of gastric GIST with atypical clinical presentation,asymptomatic progress and late diagnosis.The resected tumour,giant in diameters,was confirmed to represent the most rare histopathologic subtype of GISTs- sarcomatoid epithelioid GIST.We report this case and review the literature with a special focus on pathomorphological evaluation,biological aggressiveness and prognostic factors.To our knowledge this is the first report of giant GIST of very uncommon sarcomatoid epithelioid subtype.It is concluded that clinicians should pay attention to the fact that initial diagnosis may be delayed due to mildly asymptomatic and non-specific clinical presentation.Asymptomatic tumours diagnosed at a late stage,which is often the case,can be large on presentation.Prognosis for patients diagnosed with GIST depend on tumour size,mitotic rate,histopathologic subtype and tumour location.That is why early diagnosis and R0 resection,which is usually feasible and safe even in giant gastric sarcomatoid epithelioid subtype of GISTs,are the key factors for further treatment and good prognosis.Gustaw Lech Wojciech Korcz Emilia Kowalczyk Tomasz Guzel Marcin Radoch Ireneusz Wojciech Krasnodebski 2015World Journal of Gastroenterology2015,21,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费